Amantadine and rimantadine for influenza A in children and the elderly (Q24203853)

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antiviral therapy and prophylaxis for influenza in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

The use of antiviral drugs for influenza: recommended guidelines for practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantadine kinetics in healthy elderly men: implications for influenza prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Safety and pharmacokinetics of rimantadine small-particle aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Drugs in development for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Chinese medicinal herbs for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Medical treatment of viral pneumonia including SARS in immunocompetent adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Assessing the quality of evidence from randomized, controlled drug and nutritional supplement trials conducted among nursing home residents between 1968 and 2004: what can we learn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Comparing patient access to pharmaceuticals in the UK and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Influenza prophylaxis in the long-term care facility: a case-control study of the risk factors for adverse drug reactions to amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Health outcomes among patients receiving oseltamivir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Treatment options for 2009 H1N1 influenza: evaluation of the published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antiviral effects of Glycyrrhiza species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Mechanism of action of T-705 against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Complementary medicine for treating or preventing influenza or influenza-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Molecular basis of resistance of influenza A viruses to amantadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantadine aerosols in normal volunteers: pharmacology and safety testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Comparative therapeutic effect of aerosolized and oral rimantadine HCl in experimental human influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antivirals and the control of influenza outbreaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Evaluation of influenza vaccination in health-care workers, using rapid antigen detection test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antivirals for influenza in healthy adults: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

NMDA receptors in clinical neurology: excitatory times ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Methodological considerations for future controlled influenza treatment trials in complementary and alternative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Ribavirin small-particle aerosol treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Sustained-release fampridine for symptomatic treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

A Randomized, Controlled Study of Kan Jang versus Amantadine in the Treatment of Influenza in Volgograd

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantidine hydrochloride and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the De

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Neurologic manifestations in children with influenza B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Influenza (H5N1) viruses in poultry, Russian Federation, 2005-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antiviral agents for influenza: a comparison of cost-effectiveness data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Use of Oseltamivir to control influenza complications after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Characterization of H9N2 influenza A viruses isolated from chicken products imported into Japan from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Neuraminidase inhibitors for preventing and treating influenza in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Peginterferon alfa-2a: a review of approved and investigational uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Proton transport through influenza A virus M2 protein reconstituted in vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Prevention of Russian Influenza by Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Prevention of nosocomial influenza infection with Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Protection of Man from Natural Infection with Influenza A2 Hong Kong Virus by Amantadine: A Controlled Field Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

John F. Enders lecture 2006: antivirals for influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Re-emergence of fatal human influenza A subtype H5N1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Successful treatment of juvenile chronic arthritis with a specific antiviral agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Modulation of human motor cortex excitability by single doses of amantadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Management of influenza symptoms in healthy children: cost-effectiveness of rapid testing and antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

An off-seasonal amantadine-resistant H3N2 influenza outbreak in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antiviral therapy for influenza : a clinical and economic comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Effect of a plant polyphenol-rich extract on the lung protease activities of influenza-virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Evaluation of amantadine in artificially induced A2 and B influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Economic consequence of immediate testing for C-reactive protein and leukocyte count in new outpatients with acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Evaluation of Therapeutic Efficacy of Amantadine in Patients With Naturally Occurring A2 Influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Cyclooctylamine in the prevention of experimental human influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Combating influenza with antiviral therapy in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Preventing influenza: an overview of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Trial of amantadine in epidemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

The role of oseltamivir in the treatment and prevention of influenza in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Avian influenza virus infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antiviral treatment and prophylaxis of influenza in primary care: German recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Investigation of the Reconsultation Rate and Pharmacoeconomic Evaluation of Period of Influenza Treatment by Oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Spared an influenza pandemic for another year?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Prevention and early treatment of influenza in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Influenza--interpandemic as well as pandemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Understanding the symptoms of the common cold and influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Pandemic influenza: is an antiviral response realistic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Antiviral resistance in influenza viruses--implications for management and pandemic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Influenza vaccination for healthcare workers who work with the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Influenza: diagnosis, management, and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Amantadine and rimantadine for influenza A in children and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Vaccines for preventing influenza in healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Amantadine hydrochloride as a prophylactic in respiratory infections. A double-blind investigation of its clinical use and serology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Antivirals and antibiotics for influenza in the United States, 1995--2002

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Multiple sclerosis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Effect of inosiplex (Isoprinosine®) on induced human influenza A infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Prevention of influenza A/USSR/77 (H1N1): an evaluation of the side effects and efficacy of amantadine in recruits at Fort Sam Houston

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

A design for the evaluation of antiviral drugs in human influenza

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Rimantadine prophylaxis in children: a follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

[Recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics: influenza vaccination campaign 2006-2007]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021

Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza A infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002745.PUB3

7 January 2021